Private collective action protects corporate interests
The guest argued that the most effective way for corporate leaders to counter political pressure from the Trump administration is through private, collective industry action rather than public grandstanding or individual compliance.
The argument
Sonnenfeld noted that when individual companies like Harley Davidson or Merck stood alone, they faced severe backlash or leadership changes. Conversely, when CEOs from retail, tech, or pharma aligned privately to present a unified front, they successfully protected their business interests without causing Trump to lose face.
The thesis, stress-tested
✓ What validates it
- ✓Joint private meetings between industry coalitions and the administration resulting in favorable regulatory or tariff carve-outs
▸ Risks discussed
- ▸Industry groups like the Business Roundtable (BRT) may fail to act due to corporate cowardice
- ▸Individual companies that break ranks to act alone remain highly vulnerable to targeted boycotts
Hear it yourself
"And the Trump Rx plan, of course, is developed by these private meetings with the pharma types with them largely led by Pfizer and the others followed very well, especially, Merck and and Eli Lilly and J and J have been very effective at that."
00:00 / 00:16
AFFILIATE LINK · ZORTIX MAY EARN A COMMISSION · NEVER A RECOMMENDATION TO TRADE